Comparable stake leader
Harel Insurance Investments & Financial Services Ltd.
SEC ownership of TEVA PHARMACEUTICAL INDUSTRIES LTD
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000818686.
Disclosed value leader
Migdal Insurance & Financial Holdings Ltd.
Comparable rows
50/50
Latest evidence
05 Jun 2026
- Public ticker
- TEVA on NYSE, TEVJF on OTC
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Harel Insurance Investments & Financial Services Ltd.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Harel Insurance Investments & Financial Services Ltd.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
05 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000818686
- Issuer location
- Tel Aviv
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of TEVA PHARMACEUTICAL INDUSTRIES LTD (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Harel Insurance Investmen...
Disclosed value leader
Migdal Insurance & Financ...
Comparable rows
50/50
Latest evidence
05 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 6.3%
13D/G row: Harel Insurance Investments & Financial Services Ltd.
Showing 1-8 of 50 holder rows.
Quick read
Harel Insurance Investments & Financial Services Ltd. leads the comparable SEC ownership view at 6.3%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Harel Insurance Investments & Financial Services Ltd.'s linked filing trail.
Comparable ownership
Top 5
Harel Insurance Investments & Fin...
6.3%
Migdal Insurance & Financial Hold...
5.4%
Phoenix Financial Ltd.
5%
MENORA MIVTACHIM HOLDINGS LTD.
5%
FMR LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. |
13F
13D/G
Company
|
6.3%
from 13D/G
|
$1,384,216,000
45,956,714 shares
|
— | 31 Mar 2026 |
| Migdal Insurance & Financial Holdings Ltd. |
13D/G
13F
Company
|
5.4%
|
$2,022,794,213
61,689,363 shares
|
$0 | 31 Dec 2025 |
| Phoenix Financial Ltd. |
13F
13D/G
Company
|
5%
from 13D/G
|
$1,288,455,710
42,777,414 shares
|
— | 31 Mar 2026 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
13D/G
Company
|
5%
from 13D/G
|
$1,193,546,656
39,626,383 shares
|
— | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
2.1%
from 13D/G
|
$997,959,810
33,132,795 shares
|
— | 31 Mar 2026 |
| Amir Elstein |
3/4/5
Director
|
0.18%
|
$63,807,864
2,118,455 shares
|
— | 05 Jun 2026 |
| Roberto A. Mignone |
3/4/5
Director
|
0.04%
|
$14,680,698
487,407 shares
|
-$8,464,031 | 05 Jun 2026 |
| Sol J. Barer |
3/4/5
Director
|
0.04%
|
$13,494,091
448,011 shares
|
— | 05 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$97,132,227.
Buys
$20,988
Insiders: 1
Sells
$97,153,215
Insiders: 12
Net
-$97,132,227
Shares: -3,074,980
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 1,113
Shares: 3,076,093
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 539,926 | $0 | $18,880,464 | -$18,880,464 |
| 3-6 | 0 | 1,734,783 | $0 | $57,250,743 | -$57,250,743 |
| 6-9 | 0 | 742,589 | $0 | $20,130,823 | -$20,130,823 |
| 9-12 | 1,113 | 58,795 | $20,988 | $891,185 | -$870,197 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 37 reporting-owner rows connected to TEVA PHARMACEUTICAL INDUSTRIES LTD. Open a relationship link for the CIK-to-CIK filing trail.
Rows
37
Largest Forms 3/4/5 holder
Amir Elstein
Net 12M change
-$97,132,227
Latest report
18 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Amir Elstein | Director | $63,807,864 | Mixed | 05 Jun 2026 | ||
| Richard D. Francis | President and CEO | $40,448,121 | -$31,263,089 | -44% | Filing P/S | 05 Jun 2026 |
| Kare Schultz | President and CEO, Director | $15,013,641 | Mixed | 01 Nov 2022 | ||
| Roberto A. Mignone | Director | $14,680,698 | -$8,464,031 | -37% | Mixed | 05 Jun 2026 |
| Sol J. Barer | Director | $13,494,091 | Mixed | 05 Jun 2026 | ||
| Gerald M. Lieberman | Director | $3,920,087 | Mixed | 05 Jun 2026 | ||
| Rosemary A. Crane | Director | $3,847,498 | Mixed | 05 Jun 2026 | ||
| Perry D. Nisen | Director | $3,608,586 | Mixed | 05 Jun 2026 | ||
| Eric A. Hughes | Executive Vice President, Global R&D and Chief Medical Officer | $3,411,035 | -$4,080,884 | -54% | Filing P/S | 05 Mar 2026 |
| Ronit Satchi-Fainaro | Director | $3,385,518 | Mixed | 05 Jun 2026 | ||
| Mark Sabag | Executive Vice President, International Markets Commercial | $2,825,937 | -$13,147,688 | -82% | Filing P/S | 01 May 2026 |
| Christine Fox | EVP, U.S. Commercial | $2,247,375 | -$2,749,766 | -55% | Filing P/S | 30 Apr 2026 |
| Eliyahu Sharon Kalif | EVP, Chief Financial Officer | $2,237,374 | -$20,725,392 | -90% | Filing P/S | 11 Jun 2026 |
| Tal Zvi Zaks | Director | $2,206,711 | Mixed | 05 Jun 2026 | ||
| Richard Daniell | EVP, Europe Commercial | $1,973,727 | -$12,078,289 | -86% | Filing P/S | 05 May 2026 |
| Eric Drape | Executive VP Global Operations | $1,972,100 | Mixed | 05 Mar 2024 | ||
| Sven Dethlefs | EVP, North America Commercial | $1,609,736 | Mixed | 06 Mar 2023 | ||
| Evan Lippman | EVP, Business Development | $1,572,501 | -$1,482,367 | -49% | Filing P/S | 14 May 2026 |
| Dov Bergwerk | Acting Chief Legal Officer | $1,272,029 | Mixed | 28 Feb 2024 | ||
| Janet S. Vergis | Director | $1,254,345 | Mixed | 05 Jun 2025 |
Recent insider transactions for TEVA PHARMACEUTICAL INDUSTRIES LTD
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Matthew Shields | TEVA | Ordinary Shares | Sale | -100% | $321,547 | $32.19 | -9,989 | 0 | 18 Jun 2026 | Direct |
| Eliyahu Sharon Kalif | TEVA | Ordinary Shares | Sale | -61.9% | $3,633,308 | $34.10 | -106,563 | 65,621 | 11 Jun 2026 | Direct |
| Sol J. Barer | TEVA | Ordinary Shares | Options Exercise | 5.1% | 21,739 | 448,011 | 05 Jun 2026 | Direct | ||
| Sol J. Barer | TEVA | Restricted Share Units | Options Exercise | -100% | -21,739 | 0 | 05 Jun 2026 | Direct | ||
| Chen Lichtenstein | TEVA | Ordinary Shares | Options Exercise | 301.7% | 14,492 | 19,296 | 05 Jun 2026 | Direct | ||
| Chen Lichtenstein | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Rosemary A. Crane | TEVA | Ordinary Shares | Options Exercise | 12.8% | 14,492 | 127,739 | 05 Jun 2026 | Direct | ||
| Rosemary A. Crane | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Amir Elstein | TEVA | Ordinary Shares | Options Exercise | 0.69% | 14,492 | 2,118,455 | 05 Jun 2026 | Direct | ||
| Amir Elstein | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Gerald M. Lieberman | TEVA | Ordinary Shares | Options Exercise | 12.5% | 14,492 | 130,149 | 05 Jun 2026 | Direct | ||
| Gerald M. Lieberman | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Perry D. Nisen | TEVA | Ordinary Shares | Options Exercise | 13.8% | 14,492 | 119,807 | 05 Jun 2026 | Direct | ||
| Perry D. Nisen | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Ronit Satchi-Fainaro | TEVA | Ordinary Shares | Options Exercise | 14.8% | 14,492 | 112,401 | 05 Jun 2026 | Direct | ||
| Ronit Satchi-Fainaro | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Tal Zvi Zaks | TEVA | Ordinary Shares | Options Exercise | 24.7% | 14,492 | 73,264 | 05 Jun 2026 | Direct | ||
| Tal Zvi Zaks | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Roberto Mignone | TEVA | Ordinary Shares | Options Exercise | 13.8% | 14,492 | 119,807 | 05 Jun 2026 | Direct | ||
| Roberto Mignone | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Richard D. Francis | TEVA | Ordinary Shares | Sale | -0.52% | $211,356 | $34.35 | -6,153 | 1,177,529 | 05 Jun 2026 | Direct |
| Richard D. Francis | TEVA | Ordinary Shares | Options Exercise | 1.11% | 13,043 | 1,183,682 | 05 Jun 2026 | Direct | ||
| Richard D. Francis | TEVA | Restricted Share Units | Options Exercise | -25% | -13,043 | 39,130 | 05 Jun 2026 | Direct | ||
| Matthew Shields | TEVA | Ordinary Shares | Sale | -61.8% | $532,330 | $32.87 | -16,195 | 9,989 | 03 Jun 2026 | Direct |
| Matthew Shields | TEVA | Ordinary Shares | Options Exercise | 162.1% | 16,195 | 26,184 | 03 Jun 2026 | Direct | ||
| Matthew Shields | TEVA | Restricted Share Units | Options Exercise | -33.3% | -16,195 | 32,392 | 03 Jun 2026 | Direct | ||
| Tal Zvi Zaks | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Ronit Satchi-Fainaro | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Sol J. Barer | TEVA | Restricted Share Units | Award | 10,863 | 10,863 | 28 May 2026 | Direct | |||
| Roberto Mignone | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Perry D. Nisen | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Gerald M. Lieberman | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Amir Elstein | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Rosemary A. Crane | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Chen Lichtenstein | TEVA | Restricted Share Units | Award | 7,242 | 7,242 | 28 May 2026 | Direct | |||
| Evan Lippman | TEVA | Ordinary Shares | Sale | -87.2% | $1,482,367 | $35.58 | -41,658 | 6,095 | 14 May 2026 | Direct |
| Evan Lippman | TEVA | Ordinary Shares | Options Exercise | 85,849 | 80,103 | 14 May 2026 | Direct | |||
| Evan Lippman | TEVA | Restricted Share Units | Options Exercise | -70.7% | -85,849 | 35,524 | 14 May 2026 | Direct | ||
| Eliyahu Sharon Kalif | TEVA | Ordinary Shares | Sale | -47.1% | $5,457,375 | $35.61 | -153,251 | 172,184 | 14 May 2026 | Direct |
| Amir Weiss | TEVA | Ordinary Shares | Sale | -34.8% | $384,444 | $36.00 | -10,679 | 20,016 | 06 May 2026 | Direct |
| Richard Daniell | TEVA | Ordinary Shares | Sale | -35% | $1,062,000 | $35.40 | -30,000 | 55,755 | 05 May 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Sale | -64.1% | $5,045,118 | $34.99 | -144,180 | 80,760 | 01 May 2026 | Direct |
| Christine Fox | TEVA | Ordinary Shares | Sale | -25% | $750,620 | $35.31 | -21,258 | 63,647 | 30 Apr 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Sale | -21.6% | $1,871,816 | $30.14 | -62,102 | 224,940 | 17 Mar 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Options Exercise | 5.8% | 15,723 | 287,042 | 05 Mar 2026 | Direct | ||
| Mark Sabag | TEVA | Restricted Share Units | Options Exercise | -25% | -15,723 | 47,170 | 05 Mar 2026 | Direct | ||
| Eliyahu Sharon Kalif | TEVA | Ordinary Shares | Options Exercise | 6.52% | 19,916 | 325,435 | 05 Mar 2026 | Direct | ||
| Eliyahu Sharon Kalif | TEVA | Restricted Share Units | Options Exercise | -25% | -19,916 | 59,748 | 05 Mar 2026 | Direct | ||
| Amir Weiss | TEVA | Ordinary Shares | Options Exercise | 13% | 3,537 | 30,695 | 05 Mar 2026 | Direct | ||
| Amir Weiss | TEVA | Restricted Share Units | Options Exercise | -25% | -3,537 | 10,613 | 05 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.